Clinical Trials Logo

Clinical Trial Summary

Inborn Errors of Immunity (IEI) are a heterogeneous group of disorders characterised not only by an infectious diathesis, but by a wide variety of other clinical manifestations. Lymphoma is one of the most common malignancies in children and may be the first clinical manifestation of IEI, thereby 'hiding' the immune defect and delaying genetic/immunological diagnosis. Lymphomas, especially non-Hodgkin's lymphomas (NHL) are frequently associated with congenital defects of the immune system, in particular diffuse large B-cell lymphoma and Burkitt's lymphoma. Preliminary analyses conducted on 6 patients diagnosed with NHL allowed the identification of genetic variants in genes associated with IEI. In clinical practice, the diagnosis and choice of therapeutic treatment in patients with immunodeficiency-associated lymphoma are decisive and, due to the complex pathophysiology of the disease, it is not always possible to identify the boundary between benign and malignant proliferation. The identification of an undiagnosed immunodeficiency in patients with lymphoma will ensure the opportunity to apply targeted therapies, such as allogeneic haematopoietic stem cell transplantation, instead of standard clinical management based mainly on chemotherapy. The study aims to identify possible congenital defects of immunity, i.e. genetic disorders affecting the immune system, as responsible for the development of haematological malignancies. Through a multidisciplinary approach involving immunological analyses, genetic analyses and a thorough examination of clinical manifestations, we aim to characterise the immunological component underlying the development of paediatric lymphomas.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06332196
Study type Interventional
Source Meyer Children's Hospital IRCCS
Contact Eleonora Gambineri
Phone 0555662624
Email eleonora.gambineri@meyer.it
Status Recruiting
Phase N/A
Start date October 18, 2023
Completion date October 18, 2025

See also
  Status Clinical Trial Phase
Terminated NCT00527878 - Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome Phase 2
Completed NCT04643639 - Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis Phase 3
Completed NCT05256784 - Mountain Food and Natural Probiotic in Nutrition
Recruiting NCT04448951 - Immune Homeostasis in Sepsis and Septic Shock
Recruiting NCT03721146 - ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency
Not yet recruiting NCT06089174 - Assessment of the Increased Risk of Infection Following an Ultratrail N/A
Completed NCT02895204 - Effect of Fermented Maillard Reacted Whey Protein on Immune Function N/A
Recruiting NCT03707782 - Mechanisms of Immune Deficiency
Recruiting NCT04646525 - The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs
Active, not recruiting NCT00852943 - Screening Protocol for Genetic Diseases of Allergic Inflammation
Completed NCT03609840 - Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Not yet recruiting NCT01359384 - Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment N/A
Recruiting NCT05605808 - Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy N/A
Completed NCT03899480 - Adoptive Transfer of Haploidentical NK Cells and N-803 Phase 1
Completed NCT03051425 - Immune Benefits of Consumption of Dairy Yogurt in Elderly N/A
Active, not recruiting NCT04824651 - Covid-19 Vaccine Cohort in Specific Populations
Enrolling by invitation NCT04382508 - Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
Completed NCT02334943 - Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment N/A
Completed NCT03052491 - Effects of a 10 Component Dietary Supplement on Health and the Quality of Life N/A
Completed NCT03881566 - Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients